Glenn’s Urologic Surgery is NEW at MSK!

Posted on by

The latest version of Glenn’s Urologic Surgery has recently been added to the @MSKCC_Library collection. This eighth edition has many key features, including:

Glenn’s Urologic Surgery, 8th Edition

  • Chapters that take you logically from diagnosis, indications for surgery, and alternative therapies, through detailed descriptions of surgical technique, and finally outcomes as described in the literature.
  • Comprehensive, authoritative coverage including all current operative procedures for each region of the genitourinary tract
  • More than 1,300 high-quality illustrations to help you visualize every important aspect of surgery, including more intraoperative photos and thoroughly illustrated descriptions of relevant anatomy that open every chapter database.

Glenn’s Urologic Surgery has been established for over 30 years as a must-have surgical reference for resident and practicing urologists.  This resource may be accessed through the Library’s STAT!Ref database.

Cancer Stats in China, New Handheld Microscope and More…

Posted on by

Here are a few news worthy items in the world of cancer research:

  • A new report estimates there were 4.3 million new cancer cases and more than 2.8 million cancer deaths in China in 2015, with lung cancer the most common cancer and the leading cause of cancer death in China.
  • Mechanical engineers at the University of Washington along with other partners have developed a handheld microscope to aide clinicians in distinguishing good cells from cancerous cells right at the point of care. Read more about this technology in Biomedical Optics Express.
  • Data published in the journal Cancer Chemotherapy and Pharmacology was the key to the first ever FDA approved immunotherapy for pediatric cancer. The treatment called dinutuximab was used in clinical trials where children demonstrated improvement in overall survival.
  • Expanding lung cancer screening to include people who quit smoking more than 15 years ago could detect more cases and further reduce associated mortality, according to a study by Mayo Clinic researchers published in the Journal of Thoracic Oncology.

 

ASSIST Now an Option for All NIH Competing Grant Applications

Posted on by

ASSIST was originally launched in 2012 for multi-project applications since they didn’t fit well within the electronic submission methods available at the time. Since then, the system has been expanded to address even more challenges identified by the NIH community. As of the December 22nd release (which completes the timeline for single-project support), ASSIST is now an option for:

  • All single and multi-project, competing grant applications
  • Single-project administrative supplements
  • Single-project, post-award successor-in-interest (type 6) requests
  • Single-project, post-award change of institution (type 7) requests

While the use of ASSIST is optional, benefits include the pre-population of data from eRA Commons profiles, submission status tracking for both Grants.gov and eRA Commons, the ability to import subaward budget forms, and the ability to copy data from a previously prepared application.  For more information and resources, see NOT-OD-16-042.